ווטריינט 200 מ"ג

Maa: Israel

Kieli: heprea

Lähde: Ministry of Health

Aktiivinen ainesosa:

PAZOPANIB AS HYDROCHLORIDE 200 MG

Saatavilla:

GLAXO SMITH KLINE (ISRAEL) LTD

ATC-koodi:

L01XE11

Lääkemuoto:

FILM COATED TABLETS

Antoreitti:

PER OS

Valmistaja:

GLAXO OPERATIONS UK LIMITED

Terapeuttinen ryhmä:

PAZOPANIB

Käyttöaiheet:

Renal cell carcinoma (RCC)Votrient is indicated in adults for the first line treatment of advanced Renal Cell Carcinoma (RCC) and for patients who have received prior cytokine therapy for advanced disease.Soft tissue sarcoma (STS)Votrient is indicated for the treatment of adult patients with selective subtypes of advanced Soft Tissue Sarcoma (STS) who have received prior chemotherapy for metastatic disease or who have progressed within 12 months after (neo) adjuvant therapy.

Valtuutus päivämäärä:

2011-01-01